Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
Condition(s):Cancer; Chronic Myelomonocytic LeukemiaLast Updated:June 1, 2017Terminated
Hide Studies Not Open or Pending
Condition(s):Cancer; Chronic Myelomonocytic LeukemiaLast Updated:June 1, 2017Terminated
Condition(s):Acute Myelogenous Leukemia; Chronic Myelomonocytic LeukemiaLast Updated:February 22, 2012Terminated
Condition(s):Myelodysplastic Syndrome; Leukemia, Myelomonocytic, ChronicLast Updated:January 27, 2020Completed
Condition(s):Chronic Myelomonocytic Leukemia; Chronic Myelomonocytic Leukemia-1; Chronic Myelomonocytic Leukemia-2; Myelodysplastic/Myeloproliferative NeoplasmLast Updated:March 27, 2024Recruiting
Condition(s):Myelodysplastic Syndromes (MDS); Chronic Myelomonocytic Leukemia (CMML); Acute Myelogenous Leukemia (AML)Last Updated:November 8, 2019Completed
Condition(s):Myelodysplastic Syndromes; Leukemia, Myelomonocytic, ChronicLast Updated:March 20, 2024Active, not recruiting
Condition(s):Myelodysplastic Syndromes; Chronic Myelomonocytic Leukemia; Acute Myeloid LeukemiaLast Updated:October 31, 2022Withdrawn
Condition(s):Chronic Myelomonocytic Leukemia; Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related ChangesLast Updated:February 13, 2024Active, not recruiting
Condition(s):Myelodysplastic Syndromes; Chronic Myelomonocytic Leukemia; Acute Myeloid LeukemiaLast Updated:August 4, 2020Completed
Condition(s):Myelodysplastic Syndromes; Leukemia, Myelomonocytic, ChronicLast Updated:May 20, 2022Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.